Role of sulfated O-linked glycoproteins in zymogen granule formation.
Packaging of proteins into regulated secretory granules is mediated by the mildly acidic pH of the trans Golgi network and immature secretory granules. This need for an acidic pH indicates that ionic interactions are important. The mouse pancreatic acinar cell contains four major sulfated glycoproteins, including the zymogen granule structural component Muclin. I tested the hypothesis that sulfation and the O-linked glycosylation to which the sulfates are attached are required for normal formation of zymogen granules in the exocrine pancreas. Post-translational processing was perturbed with two chemicals: sodium chlorate was used to inhibit sulfation and benzyl-N-acetyl-alpha-galactosaminide was used to inhibit O-linked oligosaccharide elongation. Both chemicals resulted in the accumulation in the Golgi region of the cell of large vacuoles that appear to be immature secretory granules, and the effect was much more extensive with benzyl-N-acetyl-alpha-galactosaminide than chlorate. Both chemical treatments inhibited basal secretion at prolonged chase times, and again benzyl-N-acetyl-alpha-galactosaminide had a greater effect than chlorate. In addition, benzyl-N-acetyl-alpha-galactosaminide, but not chlorate, totally inhibited stimulated secretion of newly synthesized proteins. These data provide evidence for a role of sulfated O-linked glycoproteins in protein condensation and maturation of zymogen granules. Under maximal inhibition of O-linked oligosaccharide biosynthesis, anterograde post-Golgi traffic in the regulated pathway is almost totally shut down, demonstrating the importance of these post-translational modifications in progression of secretory proteins through the regulated pathway and normal granule formation in the pancreatic acinar cell.
De Lisle
Robert C
RC
Department of Anatomy and Cell Biology, University of Kansas School of Medicine, Kansas City 66160, USA. rdelisle@kumc.edu
D000116:Acetylgalactosamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000681:Amylases / Q000378:metabolism; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D002135:Calcium-Binding Proteins; D002478:Cells, Cultured; D002704:Chlorates / Q000494:pharmacology; D004268:DNA-Binding Proteins; D004792:Enzyme Precursors / Q000187:drug effects / Q000378:metabolism*; D004847:Epithelial Cells / Q000378:metabolism / Q000648:ultrastructure; D006023:Glycoproteins / Q000187:drug effects / Q000378:metabolism*; D006031:Glycosylation / Q000187:drug effects; D051379:Mice; D009077:Mucins / Q000096:biosynthesis / Q000172:deficiency / Q000187:drug effects; D015388:Organelles / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D010179:Pancreas / Q000378:metabolism* / Q000648:ultrastructure; D014176:Protein Biosynthesis / Q000187:drug effects / Q000502:physiology; D022142:Secretory Vesicles / Q000378:metabolism* / Q000648:ultrastructure; D015398:Signal Transduction / Q000502:physiology; D013430:Sulfate Adenylyltransferase / Q000037:antagonists & inhibitors / Q000378:metabolism; D013463:Sulfuric Acid Esters / Q000378:metabolism; D025521:Tumor Suppressor Proteins
D001593:Benzyl Compounds; D002135:Calcium-Binding Proteins; D002704:Chlorates; D004268:DNA-Binding Proteins; C114202:Dmbt1 protein, mouse; D004792:Enzyme Precursors; D006023:Glycoproteins; D009077:Mucins; D013463:Sulfuric Acid Esters; D025521:Tumor Suppressor Proteins; C080739:benzyl-alpha-N-acetylgalactosamine; D013430:Sulfate Adenylyltransferase; D000681:Amylases; D000116:Acetylgalactosamine; C032706:sodium chlorate